PM360 Recognizes Kantar Health’s Jeremy Brody as 2021 ELITE Winner in Transformational Leaders Category

Kantar Health, a leader in research, data and consulting for the life sciences industry, today announced that Jeremy Brody, Chief Strategy Officer, has been named a 2021 ELITE Winner in the Transformational Leaders category at the 2021 PM360 Elite Awards.

Within this category, Jeremy was honored for his stewardship of the Kantar Health growth strategy, including leading their transformation toward digital/mobile research capabilities, and transforming their commercial business from a largely traditional market research offer of researchers to a data-driven strategic offer of commercial business consultants.

Staying true to his entrepreneurial roots, Jeremy spearheaded the identification of Kantar Health’s Real World Evidence (RWE) business, which later became the cornerstone of Kantar Health’s transformative big data strategy. After forming a dedicated innovation and strategy team, he led the launch of Claritis™, an award-winning RWE data breakthrough approach to real world data analytics. “I am grateful to PM360 for this recognition, and as always, grateful to work with such an amazing group of people at Kantar Health,” said Jeremy Brody, Chief Strategy Officer, Kantar Health. “This recognition would not be possible without their contributions, so I think of this as an honor for the Kantar Health team as a whole.”

The 2021 PM360 Elite Awards recognizes the most influential people in the healthcare industry - true catalysts who are creating extraordinary results. The Transformational Leaders category honors people who change the way things work within an organization - whether that involves building a whole new organizational structure, a new way to handle projects or turning around a failing business.

The winners were profiled in PM360’s May 2021 issue. You can read their profiles online at https://www.pm360online.com/the-2021-pm360-elite-100. Additionally, a virtual event to recognize the winners will be held on June 22 at 7 pm ET.

Cerner Corporation (NASDAQ: CERN), a global healthcare technology company, acquired Kantar Health on April 1.

About Kantar Health:

Kantar Health provides data, analytics and research to the life sciences industry. As real-world evidence and commercialization partners, Kantar Health enables clients to bring safe and effective treatment to patients around the world. The team has expertise across a myriad of therapy areas, including unique thought leadership in oncology and rare diseases. For more information on how to optimize commercial launch plans, demonstrate real-world effectiveness and safety, and build ongoing value substantiation to unlock your full potential, visit www.kantar.com/health

View source version on businesswire.com: https://www.businesswire.com/news/home/20210514005043/en/